Pricing and licensing

Start with one model. Add the rest when you need them.

Subscriptions for clinical teams, metered APIs for builders and study licences for pharma.

2 months free annually

Sandbox

Researchers and developers exploring the API.

£0forever
ICIADCBispecificCAR-T
  • 500 predictions a month
  • Synthetic and de-identified data only
  • Immunotherapy model
  • Community support
Start free

Clinic

A single oncology service or private clinic.

£490per month
ICIADC +Bispecific +CAR-T
  • 5,000 predictions a month
  • 10 clinician seats
  • Patient summary PDFs
  • Add ADC or bispecific models
  • Email support
Choose Clinic
Most popular

Hospital

Cancer centres and hospital groups.

£1,900per month
ICIADCBispecificCAR-T
  • 20,000 predictions a month
  • Unlimited clinician seats
  • SMART on FHIR EHR launch
  • SSO, audit log, 99.9% SLA
  • Named clinical success lead
Choose Hospital

Pharma & Enterprise

Sponsors, CROs and health systems.

Custom
ICIADCBispecificCAR-T
  • Per-study or enterprise licence
  • All four models plus early access
  • Private VPC or on-prem
  • Co-development and fine-tuning
  • GxP-ready audit logging
Compare plans

What each plan includes.

FeaturesSandboxClinicHospitalPharma & Enterprise
Predictions included500 / month5,000 / month20,000 / monthCustom
ModelsICIICIADC +Bispecific +ICIADCBispecificICIADCBispecificCAR-T
Clinician seats210UnlimitedUnlimited
API rate limit10 / min120 / min600 / min3,000 / min
DataSynthetic and de-identifiedYour patientsYour patientsYour trials and RWD
EHR integration–CSV uploadSMART on FHIRSMART on FHIR, HL7
SSO and audit log––
DeploymentCloudCloudCloud, regionalCloud, VPC or on-prem
SupportCommunityEmailNamed success leadDedicated team
Metered model APIs

Pay per prediction.

For builders and pilots. Volume pricing starts at 50,000 calls a month.

Immunotherapy (ICI)£0.40per prediction
Antibody–drug conjugates£0.60per prediction · early access
Bispecific antibodies£0.60per prediction · early access
CAR-T cell therapyWaitlistjoin to get first access
FAQs

Questions

Is Cure-IO a medical device?

Cure-IO is clinical decision support. It informs a conversation and does not diagnose or decide treatment. Regulatory status varies by region and model, and each model card states its current intended use.

Can we license only one model?

Yes. Every plan lets you choose which therapy-class models to enable, and you can add more from the licensing portal at any time.

How do pharma study licences work?

Study licences are priced per programme and cover the indications, sites and duration you need, with optional private deployment and co-development terms.

Where is patient data processed?

In the region you choose (UK, EU or US). Inputs are de-identified, encrypted in transit and at rest, and are not used for training without a separate written agreement.

Ready to get started?

Book a demo, or start free in the Sandbox.

See how Cure-IO fits your clinic, your trial or your product. We’ll walk your clinical, data or pharma team through the models in 30 minutes.

Cure-IO FAQs

Questions?

Regulation, licensing, data handling and how each model works.

Read the FAQs

Get Cure-IO updates